サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1463704

中南米の糖尿病性足潰瘍：2030年までの市場予測 - 地域分析 - 潰瘍タイプ別、治療タイプ別、感染重症度別、エンドユーザー別

South & Central America Diabetic Foot Ulcer Market Forecast to 2030 - Regional Analysis - By Ulcer Type, Treatment Type, Infection Severity, and End User

出版日
ページ情報
英文 109 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
中南米の糖尿病性足潰瘍：2030年までの市場予測 - 地域分析 - 潰瘍タイプ別、治療タイプ別、感染重症度別、エンドユーザー別
出版日: 2024年02月05日
発行: The Insight Partners
ページ情報: 英文 109 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

中南米の糖尿病性足潰瘍市場は2022年に3億5,691万米ドルと評価され、2030年には5億4,939万米ドルに達すると予測され、2022年から2030年までのCAGRは5.5%で成長すると予測されます。

創傷ケア管理における3Dプリンティングの利用が中南米の糖尿病性足潰瘍市場を活性化

糖尿病や血管疾患によるさまざまな適応症によって引き起こされる皮膚組織の損傷は、ヘルスケアシステムに大きな負担をかけています。3Dバイオプリンティングはレイヤーベースの合成をベースとしており、新たに生成された細胞や細胞ベースの材料は、本来の組織を模倣するために分配することができます。この技術はまだ始まったばかりだが、3Dプリンティングは創傷治療業界に革命を起こす可能性があります。多くの企業が、真皮再生のための血管新生を促進するイオン放出生体材料を含む新製品の開発に携わっています。さらに、3Dバイオプリンティングは、標準的な技術では治癒が難しい大きな傷の応急処置にも役立ちます。潰瘍や創傷の治療に3Dバイオプリンティング技術を使用することは、今後数年間、糖尿病性足潰瘍市場の顕著な動向として浮上する可能性が高いです。

中南米の糖尿病性足潰瘍市場の概要

中南米の糖尿病性足潰瘍市場は、2022年から2030年にかけてCAGR 5.5%で成長すると推定されます。市場成長を促進する主な要因は、糖尿病および関連する慢性創傷の有病率の増加と老人人口の増加です。しかし、高度な創傷治療には高いコストがかかるため、市場成長の妨げとなっています。

IDF Diabetes Atlasによると、2021年、中南米における糖尿病の支出は650億米ドルを占め、2030年には800億米ドルに達すると推定されています。このように、同地域におけるヘルスケア支出の増加と糖尿病有病率の上昇は、市場成長を後押しし、最終的に創傷ケア製品の使用を増加させると予想される要因です。さらに、いくつかの市場参入企業は、臨床医が臨床知識を高め、糖尿病性足潰瘍などの慢性創傷の治療オプションを理解できるようにするための啓発・研修コースを実施しています。2021年4月、メドライン社は糖尿病性足潰瘍の高度な治療オプションを持つ臨床医を育成するため、アルゼンチンで慢性創傷ケアコースの新シリーズを開始しました。こうした取り組みがアルゼンチン市場の成長を支えると思われます。

中南米の糖尿病性足潰瘍市場の収益と2030年までの予測（金額）

中南米の糖尿病性足潰瘍市場のセグメンテーション

治療タイプに基づき、中南米の糖尿病性足潰瘍市場は高度創傷ケアドレッシング、治療機器、生物学的製剤に区分されます。2022年には、高度創傷ケアドレッシング分野が最大のシェアを占めました。

潰瘍のタイプに基づき、中南米の糖尿病性足潰瘍市場は神経虚血性潰瘍、神経障害性潰瘍、虚血性潰瘍に区分されます。神経虚血性潰瘍セグメントは2022年に最大のシェアを占めました。

感染の重症度に基づき、中南米の糖尿病性足潰瘍市場は軽度、中等度、重度に区分されます。軽症セグメントが2022年に最大シェアを占めました。

エンドユーザー別に見ると、中南米の糖尿病性足潰瘍市場は病院、外来手術センター、在宅医療に区分されます。病院セグメントが2022年に最大シェアを占めました。

国別では、中南米の糖尿病性足潰瘍市場はブラジル、アルゼンチン、その他中南米に区分されます。2022年の中南米糖尿病性足潰瘍市場はブラジルが支配的でした。

Convatec Group Plc、3M Co、Coloplast AS、Smith &Nephew Plc、B. Braun SE、Medline Industries LP、Organogenesis Inc、Molnlycke Health Care AB、MiMedx Group Incは、中南米の糖尿病性足潰瘍市場で事業を展開している大手企業です。

目次

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 中南米の糖尿病性足潰瘍市場情勢

第5章 中南米の糖尿病性足潰瘍市場：主要産業力学

  • 市場促進要因
    • 糖尿病および関連する慢性創傷の高い有病率
    • 高齢者人口の急増
  • 市場抑制要因
    • 高度な創傷治療費用の高騰
  • 市場機会
    • 新しい創傷治療製品を発表するための調査活動の活発化
  • 今後の動向
    • 創傷治療管理における3Dプリンティングの利用
  • 影響分析

第6章 糖尿病性足潰瘍市場：中南米市場分析

  • 中南米の糖尿病性足潰瘍市場収益、2022年～2030年

第7章 中南米の糖尿病性足潰瘍市場 - 収益と2030年までの予測：治療タイプ別

  • 市場収益シェア、2022年および2030年
  • 先進創傷ケアドレッシング
  • 生物製剤
  • 治療デバイス

第8章 中南米糖尿病性足潰瘍市場 - 収益と2030年までの予測：潰瘍タイプ別

  • 市場収益シェア、2022年および2030年
  • 神経障害性潰瘍
  • 虚血性潰瘍
  • 神経虚血性潰瘍

第9章 中南米糖尿病性足潰瘍市場 - 収益と2030年までの予測：感染重症度別

  • 市場収益シェア、2022年および2030年
  • 軽症、中等症、重症

第10章 中南米糖尿病性足潰瘍市場 - 収益と2030年までの予測：エンドユーザー別

  • 市場収益シェア、2022年および2030年
  • 病院
  • 外来手術センター
  • 在宅医療

第11章 糖尿病性足潰瘍市場-中南米市場分析

  • 中南米の糖尿病性足潰瘍市場、収益と2030年までの予測
      • 中南米の糖尿病性足潰瘍市場：国別
      • ブラジル
      • アルゼンチン
      • その他中南米

第12章 糖尿病性足潰瘍市場の業界情勢

  • 糖尿病性足潰瘍の世界市場における成長戦略
  • 無機的成長戦略
  • 有機的成長戦略

第13章 糖尿病性足潰瘍市場-主要企業プロファイル

  • Convatec Group Plc
  • 3M Co
  • Coloplast AS
  • Smith & Nephew Plc
  • B. Braun SE
  • Molnlycke Health Care AB
  • MiMedx Group Inc
  • Medline Industries LP
  • Organogenesis Inc.

第14章 付録

図表

List Of Tables

  • Table 1. South & Central America Diabetic Foot Ulcer Market Segmentation
  • Table 2. South & Central America Diabetic Foot Ulcer Market, by Country - Revenue and Forecast to 2030 (USD Million)
  • Table 3. Brazil Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn) - Ulcer Type
  • Table 4. Brazil Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
  • Table 5. Brazil: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings - Revenue and Forecast to 2030 (USD Million)
  • Table 6. Brazil: Diabetic Foot Ulcer Market, by Therapy Device- Revenue and Forecast to 2030 (USD Million)
  • Table 7. Brazil: Diabetic Foot Ulcer Market, by Biologics- Revenue and Forecast to 2030 (USD Million)
  • Table 8. Brazil Diabetic Foot Ulcer Market Revenue and Forecast To 2030 (US$ Mn) - Infection Severity
  • Table 9. Brazil Diabetic Foot Ulcer Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 10. Argentina Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn) - Ulcer Type
  • Table 11. Argentina Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
  • Table 12. Argentina: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings - Revenue and Forecast to 2030 (USD Million)
  • Table 13. Argentina: Diabetic Foot Ulcer Market, by Therapy Device- Revenue and Forecast to 2030 (USD Million)
  • Table 14. Argentina: Diabetic Foot Ulcer Market, by Biologics- Revenue and Forecast to 2030 (USD Million)
  • Table 15. Argentina Diabetic Foot Ulcer Market Revenue and Forecast To 2030 (US$ Mn) - Infection Severity
  • Table 16. Argentina Diabetic Foot Ulcer Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 17. Rest of South & Central America Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn) - Ulcer Type
  • Table 18. Rest of South & Central America Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
  • Table 19. Rest of South & Central America: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings - Revenue and Forecast to 2030 (USD Million)
  • Table 20. Rest of South & Central America: Diabetic Foot Ulcer Market, by Therapy Device- Revenue and Forecast to 2030 (USD Million)
  • Table 21. Rest of South & Central America: Diabetic Foot Ulcer Market, by Biologics- Revenue and Forecast to 2030 (USD Million)
  • Table 22. Rest of South & Central America Diabetic Foot Ulcer Market Revenue and Forecast To 2030 (US$ Mn) - Infection Severity
  • Table 23. Rest of South & Central America Diabetic Foot Ulcer Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 24. Recent Inorganic Growth Strategies in the Global Diabetic Foot Ulcer Market
  • Table 25. Recent Organic Growth Strategies in the Global Diabetic Foot Ulcer Market
  • Table 26. Glossary of Terms, Diabetic Foot Ulcer Market

List Of Figures

  • Figure 1. South & Central America Diabetic Foot Ulcer Market Segmentation, By Country
  • Figure 2. South & Central America Diabetic Foot Ulcer Market - Key Industry Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. South & Central America Diabetic Foot Ulcer Market Revenue (US$ Mn), 2022 - 2030
  • Figure 5. South & Central America Diabetic Foot Ulcer Market Revenue Share, by Treatment Type 2022 & 2030 (%)
  • Figure 6. Advanced Wound Care Dressings: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Alginate Dressings: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Hydrofiber Dressings: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Foam Dressings: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Collagen Dressing: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Film Dressing: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Other Dressing: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Biologics: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Growth Factors: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Skin Graft: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Therapy Device: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Negative Pressure Wound Therapy: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Ultrasound Therapy: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. South & Central America Diabetic Foot Ulcer Market Revenue Share, By Ulcer Type 2022 & 2030 (%)
  • Figure 20. Neuropathic Ulcers: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Ischemic Ulcers: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Neuro-ischemic Ulcers: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. South & Central America Diabetic Foot Ulcer Market Revenue Share, By Infection Severity 2022 & 2030 (%)
  • Figure 24. Mild: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Moderate: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. Severe: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. South & Central America Diabetic Foot Ulcer Market Revenue Share, By End User 2022 & 2030 (%)
  • Figure 28. Hospitals: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Ambulatory Surgical Centers: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 30. Home Care: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 31. Diabetic Foot Ulcer Market, By Geography, 2022 ($Mn)
  • Figure 32. South & Central America Diabetic Foot Ulcer Market, By Key Countries, 2022 and 2030 (%)
  • Figure 33. Brazil Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 34. Argentina Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 35. Rest of South & Central America Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 36. Growth Strategies in the Global Diabetic Foot Ulcer Market
目次
Product Code: BMIRE00029574

The South & Central America diabetic foot ulcer market was valued at US$ 356.91 million in 2022 and is expected to reach US$ 549.39 million by 2030; it is estimated to grow at a CAGR of 5.5% from 2022 to 2030.

Use of 3D Printing in Wound Care Management Fuels the South & Central America Diabetic Foot Ulcer Market

Skin tissue damage caused by various indications due to diabetes and vascular diseases significantly burdens the healthcare systems. 3D bioprinting is based on layer-based synthesis, wherein the newly generated cells and cell-based materials can be dispensed to mimic native tissues. Though the technology is still nascent, 3D printing can potentially revolutionize the wound care industry. Many companies are involved in developing new products involving ion-release biomaterials that promote angiogenesis for dermal regeneration. In addition, 3D bioprinting helps patch large wounds that are hard to heal with standard techniques. The use of 3D bioprinting technologies in ulcer or wound treatments is likely to emerge as a prominent trend in the diabetic foot ulcer market in the coming years.

South & Central America Diabetic Foot Ulcer Market Overview

The South & Central America diabetic foot ulcer market is estimated to grow at a CAGR of 5.5% from 2022 to 2030. Key factors driving the market growth are increasing prevalence of diabetes and related chronic wounds and the rise in geriatric population propel market growth. However, high cost of advanced wound care treatments hinders the market growth.

According to IDF Diabetes Atlas, in 2021, diabetes accounted for US$ 65 billion in expenditure in South & Central America, which is estimated to reach US$ 80 billion by 2030. Thus, the increasing healthcare spending and the rising prevalence of diabetes in the region are factors expected to boost market growth, ultimately increasing wound care product use. Additionally, several market players are implementing awareness and training courses to empower clinicians to enhance clinical knowledge and understand treatment options for chronic wounds such as diabetic foot ulcers. In April 2021, Medline launched a new series of chronic wound care courses in Argentina to train clinicians with advanced treatment options for diabetic foot ulcers. Such initiatives will support the market growth in Argentina.

South & Central America Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Diabetic Foot Ulcer Market Segmentation

Based on treatment type, the South & Central America diabetic foot ulcer market is segmented into advanced wound care dressings, therapy device, and biologics. The advanced wound care dressings segment held largest share in 2022.

Based on ulcer type, the South & Central America diabetic foot ulcer market is segmented into neuro-lschemic ulcers, neuropathic ulcers, and ischemic ulcers. The neuro-lschemic ulcers segment held largest share in 2022.

Based on infection severity, the South & Central America diabetic foot ulcer market is segmented into mild, moderate, and severe. The mild segment held largest share in 2022.

Based on end user, the South & Central America diabetic foot ulcer market is segmented into hospitals, ambulatory surgical centers, and home care. The hospitals segment held largest share in 2022.

Based on country, the South & Central America diabetic foot ulcer market is segmented into Brazil, Argentina, the Rest of South & Central America. Brazil dominated the South & Central America diabetic foot ulcer market in 2022.

Convatec Group Plc, 3M Co, Coloplast AS, Smith & Nephew Plc, B. Braun SE, Medline Industries LP, Organogenesis Inc., Molnlycke Health Care AB, and MiMedx Group Inc are some of the leading companies operating in the South & Central America diabetic foot ulcer market.

Table Of Contents

Table of Content

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. South & Central America Diabetic Foot Ulcer Market Landscape

  • 4.1 Overview

5. South & Central America Diabetic Foot Ulcer Market - Key Industry Dynamics

  • 5.1 Market Drivers:
    • 5.1.1 High Prevalence of Diabetes and Related Chronic Wounds
    • 5.1.2 Surge in Geriatric Population
  • 5.2 Market Restraints
    • 5.2.1 High Cost of Advanced Wound Care Treatments
  • 5.3 Market Opportunities
    • 5.3.1 Growing Research Activities to Unveil Novel Wound Treatment Products
  • 5.4 Future Trends
    • 5.4.1 Use of 3D Printing in Wound Care Management
  • 5.5 Impact Analysis:

6. Diabetic Foot Ulcer Market - South & Central America Market Analysis

  • 6.1 South & Central America Diabetic Foot Ulcer Market Revenue (US$ Mn), 2022 - 2030

7. South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 - by Treatment Type

  • 7.1 Overview
  • 7.2 South & Central America Diabetic Foot Ulcer Market Revenue Share, by Treatment Type 2022 & 2030 (%)
  • 7.3 Advanced Wound Care Dressings
    • 7.3.1 Overview
    • 7.3.2 Advanced Wound Care Dressings: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.3 Alginate Dressings
      • 7.3.3.1 Overview
      • 7.3.3.2 Alginate Dressings: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.4 Hydrofiber Dressings
      • 7.3.4.1 Overview
      • 7.3.4.2 Hydrofiber Dressings: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.5 Foam Dressings
      • 7.3.5.1 Overview
      • 7.3.5.2 Foam Dressings: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.6 Collagen Dressing
      • 7.3.6.1 Overview
      • 7.3.6.2 Collagen Dressing: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.7 Film Dressing
      • 7.3.7.1 Overview
      • 7.3.7.2 Film Dressing: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.8 Other Dressings
      • 7.3.8.1 Overview
      • 7.3.8.2 Other Dressing: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Biologics
    • 7.4.1 Overview
    • 7.4.2 Biologics: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.4.3 Growth Factors
      • 7.4.3.1 Overview
      • 7.4.3.2 Growth Factors: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.4.4 Skin Graft
      • 7.4.4.1 Overview
      • 7.4.4.2 Skin Graft: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Therapy Device
    • 7.5.1 Overview
    • 7.5.2 Therapy Device: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.5.3 Negative Pressure Wound Therapy
      • 7.5.3.1 Overview
      • 7.5.3.2 Negative Pressure Wound Therapy: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.5.4 Ultrasound Therapy
      • 7.5.4.1 Overview
      • 7.5.4.2 Ultrasound Therapy: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)

8. South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 - By Ulcer Type

  • 8.1 Overview
  • 8.2 South & Central America Diabetic Foot Ulcer Market Revenue Share, By Ulcer Type 2022 & 2030 (%)
  • 8.3 Neuropathic Ulcers
    • 8.3.1 Overview
    • 8.3.2 Neuropathic Ulcers: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Ischemic Ulcers
    • 8.4.1 Overview
    • 8.4.2 Ischemic Ulcers: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Neuro-ischemic Ulcers
    • 8.5.1 Overview
    • 8.5.2 Neuro-ischemic Ulcers: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)

9. South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 - By Infection Severity

  • 9.1 Overview
  • 9.2 South & Central America Diabetic Foot Ulcer Market Revenue Share, By Infection Severity 2022 & 2030 (%)
  • 9.3 Mild, Moderate, and Severe
    • 9.3.1 Overview
    • 9.3.2 Mild: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
    • 9.3.3 Moderate: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
    • 9.3.4 Severe: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)

10. South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 - By End User

  • 10.1 Overview
  • 10.2 South & Central America Diabetic Foot Ulcer Market Revenue Share, By End User 2022 & 2030 (%)
  • 10.3 Hospitals
    • 10.3.1 Overview
    • 10.3.2 Hospitals: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Ambulatory Surgical Centers
    • 10.4.1 Overview
    • 10.4.2 Ambulatory Surgical Centers: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.5 Home Care
    • 10.5.1 Overview
    • 10.5.2 Home Care: South & Central America Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)

11. Diabetic Foot Ulcer Market - South & Central America Market Analysis

  • 11.1 South & Central America Diabetic Foot Ulcer Market, Revenue and Forecast to 2030
    • 11.1.1 Overview
      • 11.1.1.1 South & Central America Diabetic Foot Ulcer Market by Country
      • 11.1.1.2 Brazil
        • 11.1.1.2.1 Brazil Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.2.2 Brazil Diabetic Foot Ulcer Market, by Ulcer Type
        • 11.1.1.2.3 Brazil Diabetic Foot Ulcer Market, by Treatment Type
        • 11.1.1.2.3.1 Brazil: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
        • 11.1.1.2.3.2 Brazil: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
        • 11.1.1.2.3.3 Brazil: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
        • 11.1.1.2.4 Brazil Diabetic Foot Ulcer Market, by Infection Severity
        • 11.1.1.2.5 Brazil Diabetic Foot Ulcer Market, by End User
      • 11.1.1.3 Argentina
        • 11.1.1.3.1 Argentina Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.3.2 Argentina Diabetic Foot Ulcer Market, by Ulcer Type
        • 11.1.1.3.3 Argentina Diabetic Foot Ulcer Market, by Treatment Type
        • 11.1.1.3.3.1 Argentina: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
        • 11.1.1.3.3.2 Argentina: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
        • 11.1.1.3.3.3 Argentina: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
        • 11.1.1.3.4 Argentina Diabetic Foot Ulcer Market, by Infection Severity
        • 11.1.1.3.5 Argentina Diabetic Foot Ulcer Market, by End User
      • 11.1.1.4 Rest of South & Central America
        • 11.1.1.4.1 Rest of South & Central America Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.4.2 Rest of South & Central America Diabetic Foot Ulcer Market, by Ulcer Type
        • 11.1.1.4.3 Rest of South & Central America Diabetic Foot Ulcer Market, by Treatment Type
        • 11.1.1.4.3.1 Rest of South & Central America: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
        • 11.1.1.4.3.2 Rest of South & Central America: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
        • 11.1.1.4.3.3 Rest of South & Central America: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
        • 11.1.1.4.4 Rest of South & Central America Diabetic Foot Ulcer Market, by Infection Severity
        • 11.1.1.4.5 Rest of South & Central America Diabetic Foot Ulcer Market, by End User

12. Diabetic Foot Ulcer Market Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in the Global Diabetic Foot Ulcer Market
  • 12.3 Inorganic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Organic Growth Strategies
    • 12.4.1 Overview

13. Diabetic Foot Ulcer Market - Key Company Profiles

  • 13.1 Convatec Group Plc
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 3M Co
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Coloplast AS
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Smith & Nephew Plc
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 B. Braun SE
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Molnlycke Health Care AB
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 MiMedx Group Inc
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Medline Industries LP
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Organogenesis Inc.
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments

14. Appendix

  • 14.1 About Us
  • 14.2 Glossary of Terms